SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

TRAW

Traws Pharma Inc.
NASDAQHealth Care

Latest close: 0.37 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell◆Adverse 8-K filing◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Aug 14, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
  2. Aug 14, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. Jul 31, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record91417 flagged findings
Reported transactions (Form 4)80since Jun 12, 2023 · and 8 other holdings
Corporate events (8-K)30since Apr 4, 2024

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

Identity

Formerly traded as ONTX.

Listing notice in force

The exchange has notified the company that it fails a continued-listing requirement (8-K, item 3.01 of Jul 31, 2026).

Deadline: Jan 25, 2027

  • minimum bid price · Nasdaq, rule 5550(a)(2) · notice of Jul 29, 2026 · pending · deadline Jan 25, 2027 (text and rule agree)

The other times

Of the 30 issuers that received this notice 1 to 2 years ago, within the following 365 days 16 regained compliance, 23 did a reverse split and 1 filed a Form 25 (delisting). An issuer can be in more than one group.

Measured on our own SEC documents: the cohort is the issuers whose notices we read, not the whole market. Historical distribution, not a prediction.

Open the 8-K at the SEC

Reverse splits in 5 years

1 reverse split in 5 years (1:25 on Sep 23, 2024) · 1:25 cumulative

The other times: of 818 securities that did their first reverse split in 5 years, a year later the median was worth 0.53× the price on the day of the split; 382 lost more than half and 209 rose (809 with a price a year later).

Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 914)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 8, 26PRE 14A ↗Shareholder meeting and votes
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · amendment
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Ikarian Capital, LLC · 9.5% · event on Jun 30, 26 · amendment
  • Aug 14, 2610-Q ↗Quarterly report
  • Aug 14, 268-K ↗Current report · Results · Communication to the market
  • Aug 14, 26SCHEDULE 13G ↗Passive stake · Sirenia Capital Management LP · 9.9% · event on Jun 30, 26
  • Aug 12, 26SCHEDULE 13G/A ↗Passive stake · Adage Capital Management, L.P. · 4.8% · event on Jun 30, 26 · amendment
  • Jul 31, 268-K ↗Current report · Listing notice (8-K 3.01)
  • Insider transaction · 10 Form 4 filingsshow all 10hide
  • Jul 10, 268-K ↗Current report · Other events
  • Jul 10, 26424B5 ↗Securities offering
  • Jul 9, 268-K ↗Current report · A senior executive left or was appointed
  • Jul 7, 26CORRESP ↗Correspondence with the SEC
  • Jul 7, 26UPLOAD ↗Correspondence with the SEC
  • Jul 1, 26S-3 ↗Securities offering
  • Jun 22, 268-K ↗Current report · Communication to the market

914 filings on record, the oldest from May 30, 13.

Listing the 25 most recent filings of the 914 on record.

8-Ks, explained

Stress24Structure39Governance34
  • Jul 31, 26StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Jul 9, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Apr 15, 26StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Governance4 senior executive changes2025show all 4hide
    • Dec 16, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Nov 28, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Oct 17, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Oct 6, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Sep 12, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Governance3 senior executive changes2025show all 3hide
    • Jul 3, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Apr 18, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Mar 28, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Mar 10, 25StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Feb 19, 25StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Feb 7, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Dec 31, 24StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Dec 20, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Nov 22, 24StressListing notice (8-K 3.01)8-K 3.01 ↗

7 older filings not shown · The record reaches back to Jul 30, 13.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

The full record holds 24 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • ORBIMED ADVISORS LLC11.9%Apr 16, 26SCHEDULE 13D/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Sirenia Capital Management LP9.9%Jun 30, 26SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • Ikarian Capital, LLC9.5%Jun 30, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Squadron Capital Management LLC8.4%Sep 30, 25SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Chernett Jorey6.8%Jan 14, 26SCHEDULE 13G ↗
  • Squadron Master Fund LP6.4%Mar 31, 26SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
show 3 more holdershide
  • Perceptive Advisors LLC6.1%Mar 31, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Adage Capital Management, L.P.4.8%Jun 30, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
  • Ayrton Capital LLC4.3%Dec 31, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum.

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Apr 16, 26Buy$998KORBIMED ADVISORS LLC↗
Stock compensation, tax and giftsshow the 39 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Dec 12, 25Compensationamount n/aCharles Nolan ParkerChief Financial Officer↗
  • Dec 12, 25Compensationamount n/aJACK E STOVER↗
  • Dec 12, 25Compensationamount n/aWERNER CAUTREELS↗
  • Dec 12, 25Compensationamount n/aJohn Harold Leaman↗
  • Dec 12, 25Compensationamount n/aIain D. DukesChief Executive Officer↗
  • Dec 12, 25Compensationamount n/aMary Teresa Shoemaker↗
  • Dec 12, 25Compensationamount n/aTrafford Clarke↗
  • Dec 12, 25Compensationamount n/aNikolay SavchukChief Operating Officer↗
  • Dec 12, 25Compensationamount n/aCharles David PauzaChief Science Officer Virology↗
  • Dec 12, 25Compensationamount n/aRobert RedfieldChief Medical Officer↗
  • Apr 2, 25Otheramount n/aTPAV, LLC↗
  • Feb 18, 25Compensation$963WERNER CAUTREELSChief Executive Officer↗
  • Jun 18, 24Tax$1KMark Patrick GuerinCFO↗
  • Jun 10, 24Compensationamount n/aMark Patrick GuerinCFO↗
  • Apr 1, 24Compensationamount n/aIain D. DukesExecutive Chairman↗
  • Apr 1, 24Compensationamount n/aIain D. DukesExecutive Chairman↗
  • Apr 1, 24Compensationamount n/aIain D. DukesExecutive Chairman↗
  • Apr 1, 24Compensationamount n/aNikolay SavchukChief Operating Officer↗
  • Apr 1, 24Compensationamount n/aNikolay SavchukChief Operating Officer↗
  • Apr 1, 24Compensationamount n/aNikolay SavchukChief Operating Officer↗
  • Apr 1, 24Compensationamount n/aNikolay SavchukChief Operating Officer↗
  • Apr 1, 24Compensationamount n/aWERNER CAUTREELSChief Executive Officer↗
  • Apr 1, 24Compensationamount n/aCharles David PauzaChief Science Officer Virology↗
  • Apr 1, 24Compensationamount n/aRobert RedfieldActing Chief Medical Officer↗
  • Apr 1, 24Compensationamount n/aNikolay SavchukChief Operating Officer↗
  • Apr 1, 24Compensationamount n/aIain D. DukesExecutive Chairman↗
  • Mar 14, 24Tax$8KSteven M FruchtmanPRESIDENT, CHIEF EXECUTIVE OFF↗
  • Mar 14, 24Tax$2KMark Patrick GuerinCFO AND COO↗
  • Mar 13, 24Compensationamount n/aSteven M FruchtmanPRESIDENT, CHIEF EXECUTIVE OFF↗
  • Mar 13, 24Compensationamount n/aMark Patrick GuerinCFO AND COO↗
  • Feb 7, 24Compensationamount n/aSteven M FruchtmanPRESIDENT, CHIEF EXECUTIVE OFF↗
  • Feb 7, 24Tax$6KSteven M FruchtmanPRESIDENT, CHIEF EXECUTIVE OFF↗
  • Feb 7, 24Compensationamount n/aMark Patrick GuerinCFO AND COO↗
  • Feb 7, 24Tax$2KMark Patrick GuerinCFO AND COO↗
  • Aug 3, 23Tax$5KSteven M FruchtmanPRESIDENT, CHIEF EXECUTIVE OFF↗
  • Aug 3, 23Tax$1KMark Patrick GuerinCFO AND COO↗
  • Aug 2, 23Compensationamount n/aSteven M FruchtmanPRESIDENT, CHIEF EXECUTIVE OFF↗
  • Aug 2, 23Compensationamount n/aMark Patrick GuerinCFO AND COO↗
  • Jun 12, 23Compensationamount n/aMark Patrick GuerinCFO AND COO↗

The full record holds 47 transactions and goes back to Feb 7, 23.

Its sector and its market

Traws Pharma Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Traws Pharma Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Traws Pharma Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
Series with incidents in the period; the chart shows what could be kept.
SEC records
914 documents on file, from May 30, 2013 to Oct 8, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.